Lupus & antiphospholipid syndrome
Prevalence of Systemic Lupus Erythematosus in Australia, 2010–2022: A Population‐Based Study Using Linked National Administrative Health Data
Authors' conclusion
This is the first Australian SLE study using comprehensive linked administrative health data, and it identified higher prevalence than previously reported, more closely aligning with international estimates.
Study context
- Population
- General population of Australia, National Health Data Hub (dispensed medications, subsidised medical services, hospital admissions, deaths), 2010–2022individuals with systemic lupus erythematosus (SLE)
- Participants
- 26,788 participants
- Exposure
- Certain vs Uncertain
- Certainn = 16,294
- Uncertainn = 10,494
- Outcome
- Period prevalence of SLE
- Follow-up
- 2010-2022
Methodological detailsalgorithm-based case identification, expert panel of rheumatologists
- Algorithm-based case identification
- Expert panel of rheumatologists
Main finding
As reported in the abstract
Period prevalence of SLE in Australia · 2010 to 2022
Period prevalence per 100,000 (certain cases or overall cases)
77 to 127 per 100,000
Observational data: associations, not effects.
Further findings
Care for SLE only in an outpatient setting, certain cases
- Just over half of certain cases
Original publication
Prevalence of Systemic Lupus Erythematosus in Australia, 2010–2022: A Population‐Based Study Using Linked National Administrative Health Data. Arthritis Care Res (Hoboken). Published 7 April 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →